X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs TTK HEALTHCARE - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD TTK HEALTHCARE MERCK LTD/
TTK HEALTHCARE
 
P/E (TTM) x 26.5 29.4 90.0% View Chart
P/BV x 3.0 5.4 54.7% View Chart
Dividend Yield % 1.0 0.5 178.0%  

Financials

 MERCK LTD   TTK HEALTHCARE
EQUITY SHARE DATA
    MERCK LTD
Dec-16
TTK HEALTHCARE
Mar-14
MERCK LTD/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,060663 159.8%   
Low Rs623399 156.1%   
Sales per share (Unadj.) Rs632.4535.6 118.1%  
Earnings per share (Unadj.) Rs45.715.9 286.7%  
Cash flow per share (Unadj.) Rs62.320.0 311.2%  
Dividends per share (Unadj.) Rs11.004.00 275.0%  
Dividend yield (eoy) %1.30.8 173.6%  
Book value per share (Unadj.) Rs388.8137.6 282.5%  
Shares outstanding (eoy) m16.607.77 213.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.31.0 134.2%   
Avg P/E ratio x18.433.3 55.3%  
P/CF ratio (eoy) x13.526.5 50.9%  
Price / Book Value ratio x2.23.9 56.1%  
Dividend payout %24.125.1 95.9%   
Avg Mkt Cap Rs m13,9694,127 338.4%   
No. of employees `0001.61.7 92.7%   
Total wages/salary Rs m1,487607 245.1%   
Avg. sales/employee Rs Th6,631.92,436.7 272.2%   
Avg. wages/employee Rs Th939.2355.2 264.4%   
Avg. net profit/employee Rs Th479.472.5 660.9%   
INCOME DATA
Net Sales Rs m10,4984,162 252.3%  
Other income Rs m24261 396.1%   
Total revenues Rs m10,7414,223 254.3%   
Gross profit Rs m1,135197 576.0%  
Depreciation Rs m27632 869.1%   
Interest Rs m030 0.0%   
Profit before tax Rs m1,102197 560.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m34373 471.6%   
Profit after tax Rs m759124 612.5%  
Gross profit margin %10.84.7 228.3%  
Effective tax rate %31.137.0 84.2%   
Net profit margin %7.23.0 242.8%  
BALANCE SHEET DATA
Current assets Rs m6,4101,629 393.5%   
Current liabilities Rs m8,8281,058 834.6%   
Net working cap to sales %-23.013.7 -168.0%  
Current ratio x0.71.5 47.2%  
Inventory Days Days5830 193.7%  
Debtors Days Days3834 114.3%  
Net fixed assets Rs m1,406556 252.8%   
Share capital Rs m16678 213.6%   
"Free" reserves Rs m6,286878 715.7%   
Net worth Rs m6,4551,069 603.6%   
Long term debt Rs m0159 0.0%   
Total assets Rs m8,8282,399 367.9%  
Interest coverage xNM7.6-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.21.7 68.6%   
Return on assets %8.66.4 134.1%  
Return on equity %11.811.6 101.5%  
Return on capital %17.118.5 92.5%  
Exports to sales %8.30.8 1,047.6%   
Imports to sales %21.01.4 1,502.2%   
Exports (fob) Rs m86933 2,642.6%   
Imports (cif) Rs m2,20958 3,789.4%   
Fx inflow Rs m95933 2,914.3%   
Fx outflow Rs m2,61263 4,133.6%   
Net fx Rs m-1,653-30 5,457.9%   
CASH FLOW
From Operations Rs m1,070127 845.5%  
From Investments Rs m-750-146 513.5%  
From Financial Activity Rs m-15022 -684.0%  
Net Cashflow Rs m1713 6,836.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 3.7 491.9%  
FIIs % 1.0 5.2 19.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 25.8 112.8%  
Shareholders   28,591 12,723 224.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   SUVEN LIFE  SUN PHARMA  PFIZER  GLENMARK PHARMA  SHASUN PHARMA  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 22, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - NATCO PHARMA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS